· Sarah Gladstone, MD · Genetics 101

Early Genetic Diagnosis Helps Advance New Treatments

An early diagnosis does more than guide one child's care. Each new diagnosis also helps researchers understand a condition better—and makes new treatments more likely for every family living with it.

An early diagnosis does more than guide one child's care. Each new diagnosis also helps researchers understand a condition better—and makes new treatments more likely for every family living with it.

Genetic testing can provide children and their families with important answers about their health. Identifying a genetic condition early can do something else: it can help move research and treatment development forward for that condition.

Finding people who might otherwise go undiagnosed

When a genetic condition is first discovered, it is often recognized in people with the most noticeable or severe symptoms. Over time, genetic testing may reveal that the condition has a much broader range of symptoms—a broader phenotype. Some people may have a milder phenotype, with more subtle symptoms, from the onset of their disease. Others may not develop recognizable symptoms until later in life.

Without genetic testing, these individuals may never receive the correct diagnosis for their condition, and the medical community would not have a clear understanding of what that condition can look like.

More diagnoses, more research, more treatments

For rare genetic conditions, one of the biggest barriers to treatment development is simply having too few identified patients. When more people receive an accurate diagnosis, the entire research ecosystem can grow.

A larger diagnosed community can lead to:

  • More community-driven research funding. A larger patient and family community can increase awareness, fundraising, philanthropy, and partnerships with researchers.
  • A stronger collective voice. More diagnosed individuals and families can bring greater attention to unmet medical needs for a given condition, and encourage investment in research and treatment development.
  • More researchers studying the condition, and better research tools. A better-defined patient population makes a disease more feasible and scientifically attractive to study. Increased scientific interest can lead to cell models, animal models, antibodies, assays, and other research reagents that can be shared across laboratories.
  • Stronger disease registries and natural-history studies. People who are diagnosed can choose to participate in registries, helping researchers understand how a condition changes over time and how much it varies from person to person. That provides evidence of how the disease unfolds—and the ability to compare a treatment against it.
  • More potential treatments being investigated. Researchers and companies have more opportunities to test different therapeutic approaches.
  • More potential clinical-trial participants. Rare-disease trials can struggle to enroll enough participants. Identifying people before a trial begins can make studies more practical and potentially faster to complete.
  • Greater potential public-health impact. If genetic testing reveals that a condition is more common than previously believed, successful treatment could benefit more people. That information can influence research priorities and the feasibility of drug-development programs. It can also save lives.

A diagnosis for one creates a clearer picture for all

For an individual family, an early diagnosis can provide opportunities for proactive care. For the larger community, every diagnosis adds to our understanding of the condition, strengthens patient registries and research, expands opportunities for clinical trials, and helps researchers develop and test emerging treatments.

An earlier diagnosis may also change what is possible with treatment. As more people are identified before significant symptoms develop, researchers may discover opportunities to intervene earlier—protecting healthy cells and function rather than trying to restore them after damage has occurred. Even when no treatment is currently available, identifying people earlier helps build the knowledge and research foundation needed to develop one.

Knowledge today can help change tomorrow

The goal of early genetic diagnosis is not simply to find a condition sooner. It is to create opportunities to protect health today while building a pathway toward earlier—and ultimately preventive—treatments for the future.

The more we understand about who has a genetic condition, and how that condition affects different individuals, the better positioned researchers, clinicians, patient organizations, and drug developers are to find and test new treatments.

A genetic diagnosis is not a label. It is a starting point—a chance to understand a child’s health more fully, make informed decisions, connect with appropriate care, and help accelerate treatment development. Knowing a diagnosis today helps shape a healthier tomorrow.


This article is for informational purposes only and is not a substitute for professional medical advice. If you have concerns about your child’s health, speak with your pediatrician.